Corporate Board Profile
| Filing Date | Source Excerpt |
|---|---|
| 2009-04-22 | Jason M. Aryeh, age 40, has been a director of the Company since 2006. He is the founder and general partner of JALAA Equities, LP, a private hedge fund formed in 1996 with a focus on biotechnology and specialty pharmaceutical companies. |
| 2010-04-16 | Jason M. Aryeh, age 41, has been a director of the Company since 2006. He is the founder and general partner of JALAA Equities, LP, a private hedge fund formed in 1996 with a focus on biotechnology and specialty pharmaceutical companies. |
| 2011-04-20 | Mr. Aryeh also serves on the board of directors of Ligand Pharmaceuticals, a public biotechnology company, CorMatrix Cardiovascular, a medical device company, and the Cystic Fibrosis Foundation’s Therapeutics Board (CFFT). |
Data sourced from SEC filings. Last updated: 2025-04-27